StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck organon & Co. — Total Revenues ($M) ($M)

Organon & Co. SEC Filings (NYSE: OGN, CIK 0001821825, spun off June 2, 2021)

QuarterlyAnnual
Latest, Q2 2026
1,558
Period ended Jun 30, 2026
Change on a year earlier
-2.3%
1,594 in Q2 2025
History
26 quarters
Since Q1 2020
Sources
21
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganon & Co. — Total Revenues ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,558-2.3%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2026Mar 31, 20261,460-3.5%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q4 2025Dec 31, 20251,507-5.3%Organon & Co. SEC Filing (0001628280-26-011125) ↗
Q3 2025Sep 30, 20251,602+1.3%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2025Jun 30, 20251,594-0.8%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2025Mar 31, 20251,513-6.7%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q4 2024Dec 31, 20241,592-0.4%Organon & Co. SEC Filing (0001628280-26-011125) ↗
Q3 2024Sep 30, 20241,582+4.1%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2024Jun 30, 20241,607-0.1%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2024Mar 31, 20241,622+5.5%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q4 2023Dec 31, 20231,598+7.6%Organon & Co. SEC Filing (0001628280-26-011125) ↗
Q3 2023Sep 30, 20231,519-1.2%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2023Jun 30, 20231,608+1.5%Organon & Co. SEC Filing (0001821825-24-000083) ↗
Q1 2023Mar 31, 20231,538-1.9%Organon & Co. SEC Filing (0001821825-24-000056) ↗
Q4 2022Dec 31, 20221,485-7.4%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2022Sep 30, 20221,537-3.9%Organon & Co. SEC Filing (0001821825-23-000013) ↗

Breakdown

What makes up organon & co. — total revenues ($m)

Cite this data

StockData. (2026). Merck Organon & Co. — Total Revenues ($M) ($M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn_rev_tot

See every metric in the Merck KPI table. Data updated Oct 26, 2026.